PITTSBURGH--(EON: Enhanced Online News)--As part of an ongoing effort to drive awareness of its product portfolio, RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, has launched a redesigned corporate website at www.redpathip.com. The website provides a contemporary look and feel that is streamlined and user-friendly, not only for physicians and patients, but also for anyone looking for information on RedPath’s growing product pipeline. The site was designed using the latest technology so that it is compatible with tablets and mobile devices in addition to standard computers.
“We are very excited about the launch of the redesigned RedPath website. The improved navigation and functionality offers quick and easy access for a broad spectrum of individuals seeking information about RedPath and our cutting-edge work in the molecular diagnostics arena”
This launch coincides with the release of a new, secure online ordering system for RedPath’s customers. RedPath’s Ordering System and Information Exchange program — known as R.O.S.I.E. — is a web-based portal that allows physicians to easily order tests, track specimens, upload medical records, and request specimen storage. Users can also download test requisitions and view final reports for all patients.
“We are very excited about the launch of the redesigned RedPath website. The improved navigation and functionality offers quick and easy access for a broad spectrum of individuals seeking information about RedPath and our cutting-edge work in the molecular diagnostics arena,” stated Dennis M. Smith, Jr., M.D., president and chief executive officer of RedPath Integrated Pathology.
“As a dynamic company, we are always looking for innovative ways to provide outstanding service to our customers. Our online ordering system allows physicians to place test orders electronically and obtain patient results any time, anywhere. R.O.S.I.E. simplifies the ordering process, saves time, and, most importantly, reduces errors. Offering the most up-to-date technology is yet another example of how RedPath is focused on helping physicians resolve complex patient management dilemmas,” added Dr. Smith.
By improving the online experience for our physicians and their patients, RedPath can further increase awareness of its proprietary products and offer industry-leading client support.
About RedPath Integrated Pathology
RedPath Integrated Pathology, Inc. is a Pittsburgh-based molecular diagnostics laboratory focused on providing novel solutions for clinicians. RedPath’s patented PathFinderTG® platform produces mutational profiles to help physicians resolve complex diagnostic dilemmas in patients who are at risk of cancer. RedPath performs all clinical testing and R&D in its state-of-the-art, CLIA-certified and CAP-accredited laboratory.
The PathFinderTG platform is supported by more than 20 years of scientific and clinical research, and studies using it have been published in more than 200 peer-reviewed journals, including The New England Journal of Medicine. Based on the strong clinical data supporting this platform, RedPath has received positive coverage decisions from Medicare and private payers. For more information about RedPath Integrated Pathology, Inc., visit www.redpathip.com or contact Andrew Mignatti at 412-224-6100.